Page last updated: 2024-08-23

simvastatin and Arterial Diseases, Carotid

simvastatin has been researched along with Arterial Diseases, Carotid in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (4.00)	18.2507
2000's	15 (60.00)	29.6817
2010's	7 (28.00)	24.3611
2020's	2 (8.00)	2.80

Authors

Authors	Studies
Kim, DH; Kim, H; Lee, CW; Lee, JS; Lee, PH; Lee, SW; Moon, DH; Oh, M; Shin, EW; Sung, C	1
Bemtgen, X; Bode, C; Grundmann, S; Helbing, T; Hoefer, I; Hohnloser, C; Jaenich, C; Juschkat, M; Kreuzaler, S; Martin, J; Mastroianni, J; Moser, M; Pankratz, F; Pasterkamp, G; Schneider, L; Smolka, C; Zeiser, R	1
Gao, Z; Jiang, H; Lu, X; Ruan, Z; Wang, Z; Wu, B; Ye, X	1
Khera, AV; Patel, PJ; Rader, DJ; Reilly, MP	1
de Martin, R; Demyanets, S; Gröger, M; Heinz, M; Huber, K; Huk, I; Kaun, C; Krychtiuk, KA; Lemberger, CE; Petzelbauer, P; Rauscher, S; Stojkovic, S; Wojta, J	1
Chai, YS; Fu, WJ; Ke, J; Lei, T; Nie, H; Pan, JH; Paranjpe, M; Qu, L; Wang, ZH; Wu, G; Xu, RH; Xu, XY; Yan, YX; Yin, Z	1
D'Agata, BM; Scardi, S; Umari, P	1
Spence, JD	1
Airan-Javia, SL; Mohler, E; Reilly, MP; Tadesse, M; Wolf, RL; Wolfe, ML	1
Gong, DW; Hu, Y; Pan, J; Ryan, K; Shuldiner, AR; Tong, G; Xu, W; Yang, R; Zhu, D	1
Avellone, G; Campisi, D; Di Garbo, V; Guarnotta, V; Parrinello, G; Purpura, L; Scaglione, R; Torres, D	1
Athyros, VG; Karagiannis, A; Katsiki, N; Mikhailidis, DP	1
Huo, QP; Liu, HY; Wang, YX	1
Bell, PR; Loftus, IM; Molloy, KJ; Naylor, AR; Schwalbe, EC; Thompson, MM	1
Adams, GJ; Ballantyne, CM; Greene, J; Harrist, R; Insull, W; Karmonik, C; Kimball, KT; Morrisett, JD; Vick, GW	1
Bellasi, A; Raggi, P	1
Busser, E; de Kleijn, DP; de Vries, JP; Koekkoek, JA; Moll, FL; Pasterkamp, G; Schoneveld, A; van der Wal, AC; Velema, E; Verheijen, JH; Verhoeven, BA; Virmani, R	1
Chu, B; Hatsukami, TS; Phan, BA; Polissar, N; Yuan, C; Zhao, XQ	1
Demirtunc, R; Duman, D; Esertas, K; Sahin, S	1
Stein, EA	1
Rackley, CE	1
Young, JH	1
Bond, MG; Schminke, U; Tang, R	1
Crook, MA; Mikhalidis, DP; Reynolds, TM; Wierzbicki, AS	1

Reviews

2 review(s) available for simvastatin and Arterial Diseases, Carotid

Article	Year
[Atherosclerosis imaging to assess plaque progression]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2005, Volume: 6, Issue:8 Topics: Adult; Aged; Animals; Aortic Diseases; Arteriosclerosis; Calcinosis; Cardiovascular Diseases; Carotid Artery Diseases; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Cost-Benefit Analysis; Disease Progression; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Magnetic Resonance Imaging; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Simvastatin; Time Factors; Tomography, X-Ray Computed	2005
Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease. Clinical cardiology, 1996, Volume: 19, Issue:9 Topics: Carotid Artery Diseases; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Simvastatin	1996

Article

Year

[Atherosclerosis imaging to assess plaque progression].

Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2005, Volume: 6, Issue:8

Topics: Adult; Aged; Animals; Aortic Diseases; Arteriosclerosis; Calcinosis; Cardiovascular Diseases; Carotid Artery Diseases; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Cost-Benefit Analysis; Disease Progression; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Magnetic Resonance Imaging; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Factors; Simvastatin; Time Factors; Tomography, X-Ray Computed

2005

Monotherapy with HMG-CoA reductase inhibitors and secondary prevention in coronary artery disease.

Clinical cardiology, 1996, Volume: 19, Issue:9

Topics: Carotid Artery Diseases; Clinical Trials as Topic; Coronary Artery Disease; Coronary Disease; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Pravastatin; Simvastatin

1996

Trials

5 trial(s) available for simvastatin and Arterial Diseases, Carotid

Article	Year
Atheroprotective lipoprotein effects of a niacin-simvastatin combination compared to low- and high-dose simvastatin monotherapy. American heart journal, 2009, Volume: 157, Issue:4 Topics: Aged; Aged, 80 and over; Carotid Artery Diseases; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins; Magnetic Resonance Spectroscopy; Male; Middle Aged; Niacin; Retrospective Studies; Simvastatin; Treatment Outcome; Ultracentrifugation	2009
Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis. Diabetes & vascular disease research, 2009, Volume: 6, Issue:4 Topics: Adipokines; Adiponectin; Anti-Inflammatory Agents; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Interleukin-6; Male; Middle Aged; Serum Amyloid A Protein; Simvastatin; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2009
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. International angiology : a journal of the International Union of Angiology, 2010, Volume: 29, Issue:6 Topics: Aged; Analysis of Variance; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Azetidines; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cholesterol; Cholesterol, HDL; Drug Combinations; Ezetimibe, Simvastatin Drug Combination; Female; Fibrinogen; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Inflammation Mediators; Italy; Male; Middle Aged; Myocardial Infarction; Primary Prevention; Secondary Prevention; Simvastatin; Time Factors; Treatment Outcome; Triglycerides; Ultrasonography	2010
Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. Magnetic resonance imaging, 2004, Volume: 22, Issue:9 Topics: Aged; Aged, 80 and over; Algorithms; Anticholesteremic Agents; Arteriosclerosis; Atorvastatin; Carotid Arteries; Carotid Artery Diseases; Disease Progression; Female; Follow-Up Studies; Heptanoic Acids; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Observer Variation; Pilot Projects; Pravastatin; Pyrroles; Reproducibility of Results; Simvastatin	2004
The effects of simvastatin and levothyroxine on intima-media thickness of the carotid artery in female normolipemic patients with subclinical hypothyroidism: a prospective, randomized-controlled study. Journal of cardiovascular medicine (Hagerstown, Md.), 2007, Volume: 8, Issue:12 Topics: Adult; Carotid Artery Diseases; Carotid Artery, Common; Cholesterol; Cholesterol, LDL; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypothyroidism; Middle Aged; Prospective Studies; Simvastatin; Thyrotropin; Thyroxine; Time Factors; Treatment Outcome; Triglycerides; Tunica Intima; Tunica Media; Ultrasonography	2007

Other Studies

18 other study(ies) available for simvastatin and Arterial Diseases, Carotid

Article	Year
Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation. Medicine, 2021, Mar-12, Volume: 100, Issue:10 Topics: Acute Coronary Syndrome; Aged; C-Reactive Protein; Carotid Arteries; Carotid Artery Diseases; Cholesterol, LDL; Clinical Trials as Topic; Datasets as Topic; Ezetimibe, Simvastatin Drug Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Rosuvastatin Calcium; Simvastatin	2021
MicroRNA-100 Suppresses Chronic Vascular Inflammation by Stimulation of Endothelial Autophagy. Circulation research, 2018, 02-02, Volume: 122, Issue:3 Topics: Animals; Atherosclerosis; Autophagy; Carotid Artery Diseases; Cell Adhesion Molecules; Cholesterol, LDL; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Leukocytes; Macrophages; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Receptors, LDL; Simvastatin; Specific Pathogen-Free Organisms; TOR Serine-Threonine Kinases; Transcriptome; Vasculitis	2018
Simvastatin reduces atherosclerotic plaques and endothelial inflammatory response in atherosclerosis rats through TGF-β/Smad pathway. Minerva medica, 2020, Volume: 111, Issue:5 Topics: Animals; Anticholesteremic Agents; Aorta; Carotid Artery Diseases; Coronary Artery Disease; Interleukin-10; Interleukin-1beta; Interleukin-6; Lipids; Plaque, Atherosclerotic; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-1; Simvastatin; Smad Proteins; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta	2020
The addition of niacin to statin therapy improves high-density lipoprotein cholesterol levels but not metrics of functionality. Journal of the American College of Cardiology, 2013, Nov-12, Volume: 62, Issue:20 Topics: Aged; Carotid Artery Diseases; Cholesterol, HDL; Clinical Trials as Topic; Female; Humans; Hypolipidemic Agents; Male; Niacin; Randomized Controlled Trials as Topic; Simvastatin	2013
Interleukin-33 induces urokinase in human endothelial cells--possible impact on angiogenesis. Journal of thrombosis and haemostasis : JTH, 2014, Volume: 12, Issue:6 Topics: Angiogenesis Inducing Agents; Carotid Arteries; Carotid Artery Diseases; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1 Receptor-Like 1 Protein; Interleukin-33; Interleukins; Neovascularization, Physiologic; NF-kappa B; Plaque, Atherosclerotic; Receptors, Cell Surface; Recombinant Proteins; RNA Interference; RNA, Messenger; Signal Transduction; Simvastatin; Time Factors; Transfection; Up-Regulation; Urokinase-Type Plasminogen Activator	2014
Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosis. Journal of ethnopharmacology, 2017, Jan-04, Volume: 195 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta, Thoracic; Aortic Diseases; Apoptosis; Atherosclerosis; Biomarkers; Carotid Artery Diseases; Cholecalciferol; Diet, High-Fat; Disease Models, Animal; Drugs, Chinese Herbal; Enzymes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Inflammation Mediators; Lipids; Male; Myocardium; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats, Sprague-Dawley; Simvastatin; Tablets; Time Factors	2017
[Lower is better: ENHANCE affair]. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2008, Volume: 70, Issue:2 Topics: Anticholesteremic Agents; Azetidines; Carotid Artery Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Ezetimibe; Humans; Publication Bias; Simvastatin; Ultrasonography	2008
Is carotid intima-media thickness a reliable clinical predictor? Mayo Clinic proceedings, 2008, Volume: 83, Issue:11 Topics: Anticholesteremic Agents; Atherosclerosis; Azetidines; Carotid Arteries; Carotid Artery Diseases; Coronary Disease; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Simvastatin; Tunica Intima; Tunica Media	2008
Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. International angiology : a journal of the International Union of Angiology, 2011, Volume: 30, Issue:3 Topics: Anticholesteremic Agents; Azetidines; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Cholesterol, LDL; Creatinine; Drug Combinations; Ezetimibe, Simvastatin Drug Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Simvastatin; Time Factors; Treatment Outcome; Triglycerides	2011
Effects of Wenxiao II decoction on the expression of MCP-1 and VCAM-1 in atherosclerotic rabbits. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2012, Volume: 32, Issue:2 Topics: Animals; Carotid Artery Diseases; Chemokine CCL2; Dose-Response Relationship, Drug; Female; Male; Medicine, Chinese Traditional; Qi; Rabbits; Simvastatin; Vascular Cell Adhesion Molecule-1	2012
Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively. The American journal of cardiology, 2004, Jul-01, Volume: 94, Issue:1 Topics: Aged; Aged, 80 and over; Arteriosclerosis; Atorvastatin; Carotid Artery Diseases; Endarterectomy, Carotid; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Interleukins; Male; Matrix Metalloproteinases; Middle Aged; Pravastatin; Pyrroles; Simvastatin; Tissue Inhibitor of Metalloproteinases; Tumor Necrosis Factor-alpha; Ultrasonography	2004
Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. Stroke, 2006, Volume: 37, Issue:8 Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherosclerosis; Atorvastatin; Carotid Arteries; Carotid Artery Diseases; Cytokines; Dose-Response Relationship, Drug; Endarterectomy, Carotid; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Inflammation; Macrophages; Peptide Hydrolases; Phenotype; Pravastatin; Pyrroles; Retrospective Studies; Simvastatin	2006
Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging. The international journal of cardiovascular imaging, 2007, Volume: 23, Issue:3 Topics: Adult; Atherosclerosis; Carotid Artery Diseases; Chi-Square Distribution; Coronary Angiography; Female; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Magnetic Resonance Imaging; Male; Middle Aged; Niacin; Simvastatin	2007
In brief: Zetia and Vytorin: the ENHANCE study. The Medical letter on drugs and therapeutics, 2008, Jan-28, Volume: 50, Issue:1278 Topics: Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Carotid Artery Diseases; Cholesterol, LDL; Drug Combinations; Ezetimibe; Ezetimibe, Simvastatin Drug Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome	2008
After ENHANCE: is more LDL cholesterol lowering even better? Clinical chemistry, 2008, Volume: 54, Issue:6 Topics: Anticholesteremic Agents; Atherosclerosis; Azetidines; Biomarkers; Carotid Artery Diseases; Cholesterol, LDL; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Inflammation; Lipid Metabolism; Simvastatin	2008
Measurement of atherosclerosis progression. Lancet (London, England), 2001, Jul-28, Volume: 358, Issue:9278 Topics: Anticholesteremic Agents; Atorvastatin; Carotid Artery Diseases; Cholesterol, LDL; Heptanoic Acids; Humans; Pyrroles; Simvastatin	2001
Measurement of atherosclerosis progression. Lancet (London, England), 2001, Jul-28, Volume: 358, Issue:9278 Topics: Anticholesteremic Agents; Carotid Arteries; Carotid Artery Diseases; Cholesterol, LDL; Humans; Simvastatin	2001
Measurement of atherosclerosis progression. Lancet (London, England), 2001, Jul-28, Volume: 358, Issue:9278 Topics: Anticholesteremic Agents; Atorvastatin; Carotid Arteries; Carotid Artery Diseases; Heptanoic Acids; Humans; Hyperlipoproteinemia Type II; Pyrroles; Simvastatin	2001